background
epidem
coronaviru
diseas
began
decemb
trigger
public
health
emerg
intern
concern
pheic
aim
find
risk
factor
progress
help
reduc
risk
critic
ill
death
clinic
help
method
data
patient
march
retriev
four
databas
statist
analyz
risk
factor
criticalmort
noncrit
patient
metaanalysi
result
thirteen
studi
includ
metaanalysi
includ
total
number
patient
infect
male
older
smoke
risk
factor
diseas
progress
patient
male
ci
p
age
year
old
ci
p
current
smoke
ci
p
proport
underli
diseas
hypertens
diabet
cardiovascular
diseas
respiratori
diseas
statist
signific
higher
criticalmort
patient
compar
noncrit
patient
diabet
ci
p
hypertens
ci
p
cardiovascular
diseas
ci
p
respiratori
diseas
ci
p
clinic
manifest
fever
short
breath
dyspnea
associ
progress
diseas
fever
ci
p
short
breath
dyspnea
ci
p
laboratori
examin
aspart
amino
transferas
ast
creatinin
cr
hypersensit
cardiac
troponin
hsctni
procalcitonin
pct
lactated
hydrogenas
ldh
ddimer
predict
deterior
diseas
white
blood
cell
wbc
l
meant
better
clinic
statu
ast
ci
p
cr
ci
p
hsctni
pgml
ci
p
pct
ngml
ci
p
ldh
ci
p
ddimer
ci
p
wbc
l
ci
p
conclus
male
age
smoke
patient
might
face
greater
risk
develop
critic
mortal
condit
comorbid
hypertens
diabet
cardiovascular
diseas
respiratori
diseas
could
also
greatli
affect
prognosi
clinic
manifest
fever
short
breath
dyspnea
laboratori
examin
wbc
ast
cr
pct
ldh
hsctni
ddimer
could
impli
progress
sinc
decemb
cluster
pneumonia
attack
human
be
pathogen
design
intern
committe
taxonomi
virus
pneumonia
name
coronaviru
world
health
organ
nowaday
one
million
confirm
case
death
occur
countriesterritori
accord
report
april
th
rapidli
increas
patient
especi
critic
mortal
patient
brought
big
challeng
public
health
lai
et
al
found
mortal
correl
countri
health
care
resourc
howev
mani
countri
invas
ventil
intens
care
unit
icu
far
adequ
treatment
critic
patient
clinic
worker
pay
attent
risk
factor
critic
diseas
death
identifi
critic
patient
earli
alloc
medic
resourc
ration
time
adjust
treatment
plan
enhanc
efficaci
reduc
risk
death
articl
analyz
clinic
characterist
patient
criticalmort
ill
noncrit
ill
literatur
patient
identifi
risk
factor
patient
develop
critic
diseas
death
order
effect
predict
progress
diseas
make
earli
treatment
respons
alloc
medic
resourc
better
way
systemat
review
metaanalysi
report
accord
prefer
report
item
systemat
review
metaanalys
prisma
statement
select
relev
studi
publish
jan
mar
data
extract
evalu
literatur
qualiti
conduct
independ
investig
zzh
twl
microsoft
excel
databas
use
record
avail
inform
includ
baselin
detail
comorbid
clinic
manifest
disagr
resolv
anoth
investig
pf
minor
use
assess
bia
risk
analys
perform
use
microsoft
excel
state
softwar
version
revman
softwar
version
result
includ
studi
perform
fixedeffect
model
mantelhaenszel
method
randomeffect
model
case
signific
heterogen
studi
use
statist
assess
magnitud
heterogen
repres
low
moder
high
degre
heterogen
respect
chosen
proper
effect
model
base
analysi
result
fix
effect
model
use
random
effect
model
use
statist
heterogen
among
result
sensit
analysi
conduct
determin
sourc
heterogen
signific
clinic
heterogen
exclud
random
effect
model
use
metaanalysi
p
consid
statist
signific
base
previou
search
strategi
studi
search
onlin
databas
delet
duplic
record
total
record
retain
articl
exclud
titl
abstract
remain
articl
delet
variou
reason
last
articl
includ
metaanalysi
final
total
studi
patient
includ
figur
select
studi
publish
differ
sampl
patient
size
rang
patient
clinic
outcom
defin
icu
admiss
studi
refractori
studi
sever
studi
studi
onset
ard
studi
death
remain
investig
risk
bia
applic
concern
includ
studi
show
tabl
none
studi
consid
serious
flaw
accord
minor
assess
includ
studi
score
studi
consid
low
risk
bia
select
demograph
characterist
includ
studi
shown
tabl
result
includ
studi
total
amount
patient
show
proport
male
signific
higher
criticaldeath
group
compar
noncrit
group
male
ci
p
figur
median
age
rang
year
old
criticalmort
group
across
enrol
studi
median
age
rang
year
old
noncrit
group
median
age
gener
higher
criticaldeath
group
compar
noncrit
group
furthermor
age
year
analyz
subgroup
guan
tian
total
amount
patient
metaanalysi
show
proport
patient
older
year
higher
criticaldeath
group
compar
noncrit
group
age
year
old
ci
p
figur
five
studi
show
proport
current
smoker
statist
signific
higher
criticalmort
group
compar
noncrit
group
current
smoke
ci
p
figur
heterogen
estim
male
age
year
old
current
smoke
among
identifi
studi
comorbid
patient
includ
studi
shown
tabl
compar
differ
preval
comorbid
criticalmort
patient
noncrit
patient
diabet
cardiovascular
diseas
respiratori
diseas
heterogen
test
result
calcul
thu
fixedeffect
model
use
analys
proport
diabet
cardiovascular
diseas
respiratori
diseas
statist
signific
higher
criticalmort
group
compar
noncrit
group
ci
p
cardiovascular
diseas
ci
p
respiratori
diseas
ci
p
figur
hypertens
heterogen
test
show
given
sever
ill
sever
epidem
might
contribut
heterogen
classifi
studi
two
subgroup
accord
whether
studi
site
locat
wuhan
howev
heterogen
still
exist
random
effect
model
use
result
indic
higher
proport
hypertens
criticalmort
group
ci
p
figur
malign
fixedeffect
model
metaanalysi
show
proport
malign
higher
criticaldeath
group
yet
without
statist
signific
ci
p
figur
studi
clinic
manifest
includ
studi
total
case
clinic
featur
show
tabl
result
metaanalysi
show
tabl
fever
temperatur
proport
fever
statist
laboratori
examin
includ
studi
studi
total
case
shown
tabl
wbc
per
l
analysi
result
fix
effectmodel
show
proport
wbc
per
l
statist
lower
criticalmort
group
ci
p
ast
cr
hsctni
pgml
heterogen
test
result
calcul
use
fixedeffect
model
analys
proport
ast
cr
hsctni
pgml
statist
signific
higher
criticaldeath
group
compar
noncrit
group
ast
ci
p
cr
ci
p
hsctni
pgml
ci
p
figur
valu
pct
ngml
ldh
ddimer
respect
random
effect
model
result
metaanalysi
show
male
age
smoke
patient
might
face
greater
risk
develop
critic
mortal
condit
comorbid
hypertens
diabet
cardiovascular
diseas
respiratori
diseas
could
also
greatli
affect
prognosi
found
patient
short
breathdyspnea
like
develop
critic
ill
even
die
patient
fever
progress
better
without
fever
laboratori
examin
wbc
ast
cr
hsctni
pct
ldh
ddimer
could
impli
progress
coronaviru
envelop
nonseg
singlestrand
rna
viru
present
six
human
coronavirus
identifi
isol
lower
respiratori
tract
pneumonia
patient
unknown
caus
wuhan
identifi
seventh
human
coronavirus
attack
alveolar
epitheli
cell
via
angiotensinconvert
enzym
ace
isozym
mainli
distribut
cardiovascular
kidney
test
lung
colon
organ
main
role
incis
ang
ii
gener
ang
mediat
protect
effect
vasodil
antiinflammatori
antiprolifer
antagon
ang
iiinduc
vascular
smooth
muscl
contract
cell
prolifer
fibrosi
promot
vascular
inflamm
bind
receptor
surfac
alveolar
epitheli
cell
express
alveolar
epitheli
cell
downregul
mechan
intern
shed
viral
replic
increas
concentr
ang
ii
lead
inflammatori
respons
exud
neutrophil
macrophag
fibrin
result
loss
pulmonari
ventil
function
difficulti
maintain
oxygen
time
viral
infect
caus
imbal
respons
induc
inflammatori
storm
increas
level
inflammatori
factor
inflammatori
storm
critic
patient
releas
cytokin
caus
system
immun
injuri
may
import
caus
multipl
organ
failur
even
death
studi
found
women
less
suscept
viral
infect
men
possibl
protect
x
chromosom
sex
hormon
play
import
role
innat
adapt
immun
time
men
tend
associ
bad
lifestyl
habit
smoke
underli
diseas
result
major
critic
mortal
patient
male
bodi
immun
declin
age
elderli
patient
like
develop
critic
ill
even
die
therefor
patient
male
year
old
smoke
patient
higher
risk
develop
critic
ill
death
patient
combin
basic
diseas
diabet
hypertens
bodi
state
stress
long
time
immun
tend
low
moreov
longterm
histori
diabet
hypertens
damag
vascular
structur
like
develop
critic
diseas
infect
patient
chronic
heart
diseas
like
infect
due
weaken
heart
function
low
immun
infect
like
acut
cardiovascular
event
develop
sever
diseas
patient
previou
respiratori
diseas
chronic
obstruct
pulmonari
diseas
patient
lung
function
damag
lower
resist
viru
prone
develop
ard
thu
underli
diseas
diabet
hypertens
cardiovascular
diseas
respiratori
diseas
risk
factor
diseas
progress
consist
analyt
result
paper
common
clinic
manifest
patient
fever
cough
sputum
patient
immun
respons
low
may
manifest
normal
bodi
temperatur
short
breath
dyspnea
suggest
poor
lung
function
lack
oxygen
therefor
patient
found
difficulti
breath
fever
necessari
alert
deterior
patient
condit
viral
infect
caus
inflamm
human
bodi
variou
inflammatori
factor
produc
inflammatori
storm
caus
system
immun
damag
even
caus
multiorgan
failur
patient
laboratori
indic
show
pct
ngml
higher
risk
progress
critic
ill
studi
show
total
number
wbc
earli
stage
diseas
normal
reduc
howev
wbc
l
mean
better
clinic
outcom
paper
therefor
total
number
wbc
found
higher
previou
one
patient
may
associ
infect
aggrav
diseas
moment
clinician
might
pay
attent
patient
improv
treatment
ast
ldh
cr
moll
indic
liver
kidney
dysfunct
involv
correspond
treatment
taken
time
prevent
deterior
diseas
current
studi
shown
patient
abnorm
coagul
function
monocyt
tissu
cell
activ
injuri
caus
releas
cytokin
express
tissu
factor
final
caus
hypercoagul
blood
increas
risk
thrombosi
like
caus
ischemia
hypoxia
due
embol
viscera
lead
progress
diseas
critic
diseas
death
ddimer
indic
hypercoagul
blood
suggest
deterior
patient
time
caus
myocardi
injuri
direct
andor
indirect
action
direct
injuri
infect
cardiomyocyt
identifi
receptor
indirect
injuri
may
caus
inflammatori
storm
induc
immun
respons
andor
oxygen
suppli
imbal
induc
acut
respiratori
distress
syndrom
hsctni
strongli
suggest
possibl
deterior
patient
condit
qualiti
literatur
includ
studi
high
analysi
rigor
conclus
drawn
studi
highli
credibl
howev
metaanalysi
also
limit
studi
includ
metaanalysi
crosssect
studi
insuffici
demonstr
abil
b
patient
metaanalysi
chines
aim
use
find
studi
predict
overal
profil
patient
includ
countri
race
c
detail
patient
inform
iconograph
oxygen
ion
index
avail
studi
time
analysi
conclus
metaanalysi
still
need
verifi
relev
studi
care
design
rigor
execut
larger
sampl
size
studi
analyz
risk
factor
progress
critic
ill
death
patient
help
assess
patient
statu
identifi
critic
patient
earli
pay
close
attent
risk
factor
relev
laboratori
risk
valu
appear
time
person
treatment
regimen
need
enhanc
efficaci
reduc
risk
death
fig
flow
diagram
studi
select
process
tabl
minor
rate
scale
clearli
state
aim
consecut
patient
collect
data
endpoint
appropri
aim
studi
assess
studi
endpoint
period
appropri
aim
studi
follow
less
prospect
calcul
studi
select
control
group
control
group
compar
group
statist
analysi
global
ideal
score
compar
studi
huang
c
heterogen
analysi
carri
use
q
test
among
studi
variat
index
forest
plot
depict
comparison
incid
male
year
old
current
smoke
criticalmort
noncrit
patient
figur
metaanalysi
laboratori
examin
case
fixeffect
model
wbc
per
l
ast
cr
hsctni
pgml
randomeffect
model
pct
ngml
ldh
ddimer
heterogen
analysi
carri
use
q
test
among
studi
variat
index
forest
plot
depict
comparison
incid
laboratori
examin
criticalmort
noncrit
patient
